Download Your Copy of the Agenda

Planning whether the 4th Cell Therapy for Autoimmune Disease Summit is the right meeting for you and your team? Download the full agenda to explore the latest agenda topics, speaker faculty, and companies leading innovation across autoimmune cell therapy.

The event program provides a complete breakdown of workshops, presentations, panel discussions, and networking opportunities, helping you pinpoint the sessions most relevant to your priorities. See how leading organizations are approaching key scientific, clinical, and commercial challenges, and identify opportunities to benchmark your strategy against peers across the field.

Find Out Why These Companies Are Prioritizing Cell Therapies Treating Autoimmune Disease

Able Sciences - cell therapy autoimmune disease
Alloplex Biotherapeutics - cell therapy autoimmune disease
Cabaletta Bio logo - cell therapy autoimmune disease
CPTx  logo - cell therapy autoimmune disease
Gentibio - cell therapy autoimmune disease
Kite Pharma  - cell therapy autoimmune disease

Lupus Research Alliance - cell therapy autoimmune disease
Medical University of South Carolina- cell therapy autoimmune disease
Mesoblast  - cell therapy autoimmune disease
Nkarta - cell therapy autoimmune disease
Overland Therapeutics - cell therapy autoimmune disease
Immuthera, PolTREG - cell therapy autoimmune disease

Sail Biomedicines  - cell therapy autoimmune disease
Stanford University    - cell therapy autoimmune disease
University of Pennsylvania   - cell therapy autoimmune disease

71563

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

University of Pennsylvania

The rapid and remarkable expansion of research in the use of cell therapy to treat autoimmune diseases has revealed the great potential for these novel approaches to transform the lives of patients with these challenging diseases.

University of Pennsylvania

Untitled design (3)

The conference had a great set of attendees from academia, biotech and large pharma. This facilitated progressive and open discussion during talks, panels and roundtables.

Cabaletta Bio

Novartis[1]

It was great to hear different perspectives from leaders within our industry. It provided strategic thinking beyond data perceptions.

Novartis

Untitled design

Beyond my expectation, I could connect a lot of people who have engaged in the field in clinical or pharma, biotech, academia. This was a really important experience to make a strong relationships and network in the field.

ONO Pharmaceutical Co.